Veterinary Vaccines Market Research Report, Market Size, Industry Analysis, Share, Growth, Opportunities, Business Expansion, Forecast to 2025


Posted April 18, 2022 by Prachi001

he global veterinary vaccines market is projected to reach USD 11.3 billion by 2025 from USD 8.0 billion in 2020, at a CAGR of 7.2% between 2020 and 2025.
 
This report aims to provide detailed insights into the global Veterinary Vaccines Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth:
he global veterinary vaccines market is projected to reach USD 11.3 billion by 2025 from USD 8.0 billion in 2020, at a CAGR of 7.2% between 2020 and 2025.

The Asia Pacific veterinary vaccines market is expected to grow at the highest CAGR during the forecast period
The Asia Pacific is expected to grow at the highest rate in the veterinary vaccines market. The major factors driving the growth of this market include the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233

Key Market Players:
The prominent players in this market include Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (US), Virbac (France), Vetoquinol (France), Phibro Animal Health (US), Hester Biosciences (India), HIPRA (Spain), Biogenesis Bago (Argentina), Tianjin Ringpu (China), China Animal Husbandry (China), Jinyu Biotechnology (China), and Endovac Animal Health (US).

The live attenuated vaccines segment accounted for the largest share of the veterinary vaccines market.
Based on technology, the veterinary vaccines market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines. The live attenuated vaccines segment accounted for the largest share of the veterinary vaccines market in 2019, majorly due to the ease of administration and long-term immunity offered by these vaccines.
The porcine circovirus II segment accounted for the largest share of the porcine vaccines market in 2019.
Based on disease, the porcine vaccines market is segmented into porcine reproductive and respiratory syndrome (PRRS), porcine circovirus II, porcine parvovirus, swine influenza, swine pneumonia, and other porcine diseases. In 2019, the porcine circovirus II segment dominated this market owing to the high and growing prevalence of the infection

North America to dominate the neuromodulation market during the forecast period
In 2019, North America dominated the veterinary vaccines market, followed by Europe. The major factors driving the growth of this market include the increasing animal population, growing animal disease prevalence, rising awareness on veterinary vaccines, and the high and increasing demand for animal products in the region.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1233

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country India
Categories Health , Industry , Internet
Tags veterinary vaccines , veterinary vaccines market , veterinary vaccines market share
Last Updated April 18, 2022